Lucid Diagnostics Inc
NASDAQ:LUCD
Balance Sheet
Balance Sheet Decomposition
Lucid Diagnostics Inc
Lucid Diagnostics Inc
Balance Sheet
Lucid Diagnostics Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
0
|
0
|
54
|
22
|
19
|
22
|
|
| Cash |
0
|
0
|
54
|
22
|
19
|
22
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
3
|
2
|
3
|
2
|
|
| Total Current Assets |
0
|
1
|
57
|
24
|
22
|
25
|
|
| PP&E Net |
0
|
0
|
1
|
4
|
3
|
4
|
|
| PP&E Gross |
0
|
0
|
1
|
4
|
3
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
3
|
1
|
1
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
1
N/A
|
2
+113%
|
59
+2 594%
|
33
-45%
|
27
-16%
|
31
+13%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
2
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
1
|
2
|
3
|
3
|
|
| Short-Term Debt |
5
|
13
|
2
|
5
|
23
|
19
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
2
|
1
|
|
| Total Current Liabilities |
6
|
16
|
4
|
8
|
29
|
24
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
0
|
2
|
|
| Total Liabilities |
6
N/A
|
16
+148%
|
4
-73%
|
9
+122%
|
30
+213%
|
25
-14%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
19
|
54
|
|
| Retained Earnings |
6
|
14
|
42
|
98
|
151
|
204
|
|
| Additional Paid In Capital |
0
|
0
|
97
|
121
|
130
|
155
|
|
| Total Equity |
5
N/A
|
14
-155%
|
55
N/A
|
23
-58%
|
2
N/A
|
5
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
2
+113%
|
59
+2 594%
|
33
-45%
|
27
-16%
|
31
+13%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
37
|
37
|
35
|
41
|
42
|
63
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
|